Anti-Trop2/HER2 ADC (Biotech)

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameAnti-Trop2/HER2 ADC (Biotech)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VC linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody +[4] 
Mechanisms of ActionAnti-Trop-2Anti-HER2Tubulin polymerisation inhibitors
TargetsTumor-associated calcium signal transducer 2Receptor protein-tyrosine kinase erbB-2Tubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBiotech Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiotech Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A